Tagasi

ISO 22442-1:2020

Medical devices utilizing animal tissues and their derivatives -- Part 1: Application of risk management

Üldinfo
Kehtiv alates 15.09.2020
Direktiivid või määrused
puuduvad

Standardi ajalugu

Staatus
Kuupäev
Tüüp
Nimetus
15.09.2020
Põhitekst
02.11.2015
Põhitekst
This document applies to medical devices other than in vitro diagnostic medical devices manufactured utilizing materials of animal origin, which are non-viable or have been rendered non-viable. It specifies, in conjunction with ISO 14971, a procedure to identify the hazards and hazardous situations associated with such devices, to estimate and evaluate the resulting risks, to control these risks, and to monitor the effectiveness of that control. Furthermore, it outlines the decision process for the residual risk acceptability, taking into account the balance of residual risk, as defined in ISO 14971, and expected medical benefit as compared to available alternatives. This document is intended to provide requirements and guidance on risk management related to the hazards typical of medical devices manufactured utilizing animal tissues or derivatives such as:
a)   contamination by bacteria, moulds or yeasts;
b)   contamination by viruses;
c)   contamination by agents causing transmissible spongiform encephalopathies (TSE);
d)   material responsible for undesired pyrogenic, immunological or toxicological reactions.
For parasites and other unclassified pathogenic entities, similar principles can apply.
This document does not stipulate levels of acceptability which, because they are determined by a multiplicity of factors, cannot be set down in such an international standard except for some particular derivatives mentioned in Annex C. Annex C stipulates levels of TSE risk acceptability for tallow derivatives, animal charcoal, milk and milk derivatives, wool derivatives and amino acids.
This document does not specify a quality management system for the control of all stages of production of medical devices.
This document does not cover the utilization of human tissues in medical devices.
NOTE 1  It is not a requirement of this document to have a full quality management system during manufacture. However, attention is drawn to international standards for quality management systems (see ISO 13485) that control all stages of production or reprocessing of medical devices.
NOTE 2  For guidance on the application of this document, see Annex A.
*
*
*
PDF
169,14 € koos KM-ga
Paber
169,14 € koos KM-ga
Standardi monitooring

Teised on ostnud veel

Põhitekst

ISO 22442-2:2020

Medical devices utilizing animal tissues and their derivatives -- Part 2: Controls on sourcing, collection and handling
Uusim versioon Kehtiv alates 15.09.2020
Põhitekst

ISO 22442-3:2007

Medical devices utilizing animal tissues and their derivatives -- Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
Uusim versioon Kehtiv alates 27.11.2007
Põhitekst

ISO/TR 14283:2018

Implants for surgery -- Essential principles of safety and performance
Uusim versioon Kehtiv alates 03.01.2018
Muudatus

EVS-EN 62366-1:2015/A1:2020

Meditsiiniseadmed. Osa 1: Kasutatavusprojekteerimise rakendamine meditsiiniseadmetele
Kehtiv alates 17.08.2020